GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 17 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $109,000 | +0.9% | 12,000 | 0.0% | 0.02% | -4.8% |
Q3 2017 | $108,000 | +45.9% | 12,000 | 0.0% | 0.02% | +40.0% |
Q2 2017 | $74,000 | +27.6% | 12,000 | 0.0% | 0.02% | +25.0% |
Q1 2017 | $58,000 | +38.1% | 12,000 | 0.0% | 0.01% | +33.3% |
Q4 2016 | $42,000 | -20.8% | 12,000 | 0.0% | 0.01% | -30.8% |
Q3 2016 | $53,000 | -1.9% | 12,000 | 0.0% | 0.01% | 0.0% |
Q2 2016 | $54,000 | -8.5% | 12,000 | 0.0% | 0.01% | -13.3% |
Q1 2016 | $59,000 | -35.2% | 12,000 | 0.0% | 0.02% | -31.8% |
Q4 2015 | $91,000 | +2.2% | 12,000 | 0.0% | 0.02% | 0.0% |
Q3 2015 | $89,000 | -26.4% | 12,000 | 0.0% | 0.02% | -24.1% |
Q2 2015 | $121,000 | +7.1% | 12,000 | 0.0% | 0.03% | +7.4% |
Q1 2015 | $113,000 | +94.8% | 12,000 | +20.0% | 0.03% | +92.9% |
Q4 2014 | $58,000 | +241.2% | 10,000 | +400.0% | 0.01% | +250.0% |
Q3 2014 | $17,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ibex Investors LLC | 418,000 | $5,676,000 | 3.15% |
Knoll Capital Management, LLC | 210,000 | $2,881,000 | 2.44% |
BVF INC/IL | 1,761,567 | $23,922,000 | 2.10% |
P.A.W. CAPITAL CORP | 90,000 | $1,222,000 | 1.30% |
683 Capital Management, LLC | 1,350,000 | $18,333,000 | 1.19% |
Vivo Capital, LLC | 851,492 | $11,563,000 | 1.16% |
MEITAV INVESTMENT HOUSE LTD | 653,957 | $8,946,000 | 0.44% |
Trellus Management Company, LLC | 16,711 | $227,000 | 0.33% |
Nantahala Capital Management | 838,674 | $11,389,000 | 0.31% |
MENTA CAPITAL LLC | 49,183 | $668,000 | 0.23% |